Insulin-like growth factor binding protein, acid labile subunit, also known as IGFALS, is a protein which in humans is encoded by the IGFALSgene.[5]
Function
The protein encoded by this gene is a serum protein that binds insulin-like growth factors, increasing their half-life and their vascular localization. Production of the encoded protein, which contains twenty leucine-rich repeats, is stimulated by growth hormone. Three transcript variants encoding two different isoforms have been found for this gene.[5]
^Bocchini, Carol A. (25 August 2014). "ACID-LABILE SUBUNIT DEFICIENCY; ACLSD". OMIM - An Online Catalog of Human Genes and Genetic Disorders. Retrieved 21 February 2024.
Domené HM, Bengolea SV, Jasper HG, Boisclair YR (2005). "Acid-labile subunit deficiency: phenotypic similarities and differences between human and mouse.". J. Endocrinol. Invest. 28 (5 Suppl): 43–6. PMID16114275.
Dai J, Baxter RC (1992). "Molecular cloning of the acid-labile subunit of the rat insulin-like growth factor binding protein complex". Biochem. Biophys. Res. Commun. 188 (1): 304–9. doi:10.1016/0006-291X(92)92385-B. PMID1384485.
Sneppen SB, Lange M, Pedersen LM, Kristensen L LØ, Main KM, Juul A, Skakkebaek NE, Feldt-Rasmussen U (2002). "Total and free insulin-like growth factor I, insulin-like growth factor binding protein 3 and acid-labile subunit reflect clinical activity in acromegaly". Growth Horm. IGF Res. 11 (6): 384–91. doi:10.1054/ghir.2001.0254. PMID11914026.
Deming SL, Ren Z, Wen W, Shu XO, Cai Q, Gao YT, Zheng W (2007). "Genetic variation in IGF1, IGF-1R, IGFALS, and IGFBP3 in breast cancer survival among Chinese women: a report from the Shanghai Breast Cancer Study". Breast Cancer Res. Treat. 104 (3): 309–19. doi:10.1007/s10549-006-9420-8. PMID17063263. S2CID31516153.